logo

For the Inventor, By the Inventor

Spring, TX, United States of America

Joshua O Ojwang

This inventor holds 8 USPTO granted patents. Top assignees: Aronex Pharmaceuticals, Inc., University of California, Columbia University. Active years: 1996-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joshua O Ojwang. Retrieved from https://idiyas.com/inventor/joshua-o-ojwang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 87.5

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 61(Granted Patents)


Location History:

  • Spring, TX (US) (1996 - 2002)
  • Edmond, OK (US) (2006)

Company Filing History:

goldMedal4 out of 12 
 
Aronex Pharmaceuticals, Inc.
 patents
silverMedal3 out of 16,008 
 
University of California
 patents
bronzeMedal1 out of 2,552 
 
Columbia University
 patents
4. 1 out of 3,693 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
where one patent can have more than one assignee

Years Active: 1996-2006

Loading Chart...
8 patents (USPTO):Explore Patents
1. 7074769 - Oligonucleotide inhibitors of bcl-xL (2006-07-11),
2. 6355785 - Guanosine-rich oligonucleotide integrase inhibitors (2002-03-12),
3. 6323185 - Anti-viral guanosine-rich oligonucleotides and method of treating HIV (2001-11-27),
4. 6150339 - Anti-viral guanosine-rich oligonucleotides (2000-11-21),
5. 6132962 - Retroviral vectors comprising an anti-hiv or other nucleic acid (2000-10-17),
6. 5811275 - HIV-specific ribozymes (1998-09-22),
7. 5670361 - HIV-specific ribozymes (1997-09-23),
8. 5567604 - Anti-viral guanosine-rich oligonucleotides (1996-10-22),

Title: Innovations and Contributions of Joshua O Ojwang

Introduction

Joshua O Ojwang is a notable inventor based in Spring, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide-based therapies. With a total of 8 patents to his name, his work has the potential to impact cancer treatment and viral infections.

Latest Patents

Ojwang's latest patents include innovative methods and compositions for treating cancer and viral infections. One of his key inventions is the development of oligonucleotide inhibitors of bcl-xL. This invention provides an antisense oligonucleotide or analog that comprises 10 or more contiguous bases from specific sequences. The invention also details methods for encapsulating these oligonucleotides in liposomes or nanoparticles, enhancing their delivery to tumor cells. Additionally, Ojwang has developed guanosine-rich oligonucleotide integrase inhibitors, which offer a method for treating viral infections both in vitro and in vivo. These oligonucleotides are designed to form guanosine tetrads, showcasing their potential in antiviral therapies.

Career Highlights

Throughout his career, Joshua O Ojwang has worked with prominent organizations such as Aronex Pharmaceuticals, Inc. and the University of California. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Ojwang has collaborated with notable colleagues, including Robert F Rando and Susan Fennewald. These partnerships have further enriched his research and development efforts in biotechnology.

Conclusion

Joshua O Ojwang's innovative work in oligonucleotide therapies demonstrates his commitment to advancing medical science. His contributions have the potential to significantly improve treatment options for cancer and viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…